Bezard E - Search Results

1

Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.

Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE. Espay AJ, et al. Among authors: bezard e. Ann Neurol. 2018 Dec;84(6):797-811. doi: 10.1002/ana.25364. Epub 2018 Nov 30. Ann Neurol. 2018. PMID: 30357892 Review.

2

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.

Bezard E, Brotchie JM, Gross CE. Bezard E, et al. Nat Rev Neurosci. 2001 Aug;2(8):577-88. doi: 10.1038/35086062. Nat Rev Neurosci. 2001. PMID: 11484001 Review.

3

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

Aubert I, Guigoni C, Håkansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E. Aubert I, et al. Among authors: bezard e. Ann Neurol. 2005 Jan;57(1):17-26. doi: 10.1002/ana.20296. Ann Neurol. 2005. PMID: 15514976

4

Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.

Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, Håkansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, Bloch B, Bezard E. Guigoni C, et al. Among authors: bezard e. Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S25-9. doi: 10.1016/j.parkreldis.2004.11.005. Parkinsonism Relat Disord. 2005. PMID: 15885624 Review.

5

Preclinical development of gene therapy for Parkinson's disease.

Porras G, Bezard E. Porras G, et al. Among authors: bezard e. Exp Neurol. 2008 Jan;209(1):72-81. doi: 10.1016/j.expneurol.2007.08.003. Epub 2007 Aug 22. Exp Neurol. 2008. PMID: 17904121 Review.

6

Striatal histone modifications in models of levodopa-induced dyskinesia.

Nicholas AP, Lubin FD, Hallett PJ, Vattem P, Ravenscroft P, Bezard E, Zhou S, Fox SH, Brotchie JM, Sweatt JD, Standaert DG. Nicholas AP, et al. Among authors: bezard e. J Neurochem. 2008 Jul;106(1):486-94. doi: 10.1111/j.1471-4159.2008.05417.x. Epub 2008 Jul 1. J Neurochem. 2008. PMID: 18410512 Free article.

7

Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?

Nadjar A, Gerfen CR, Bezard E. Nadjar A, et al. Among authors: bezard e. Prog Neurobiol. 2009 Jan 12;87(1):1-9. doi: 10.1016/j.pneurobio.2008.09.013. Epub 2008 Sep 30. Prog Neurobiol. 2009. PMID: 18938208 Free PMC article. Review.

8

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.

Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M. Muñoz A, et al. Among authors: bezard e. Brain. 2008 Dec;131(Pt 12):3380-94. doi: 10.1093/brain/awn235. Epub 2008 Oct 24. Brain. 2008. PMID: 18952677

9

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E. Voon V, et al. Among authors: bezard e. Lancet Neurol. 2009 Dec;8(12):1140-9. doi: 10.1016/S1474-4422(09)70287-X. Lancet Neurol. 2009. PMID: 19909912 Review.

10

Dopamine receptors and L-dopa-induced dyskinesia.

Berthet A, Bezard E. Berthet A, et al. Among authors: bezard e. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S8-12. doi: 10.1016/S1353-8020(09)70827-2. Parkinsonism Relat Disord. 2009. PMID: 20123563 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page